Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 19, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Publication of the Revised NIH Grants Policy Statement (Rev. December 2021) for Fiscal Year 2022
National Institutes of Health
General Notices
- Notice of Clarification Regarding Institutional Eligibility for PAR-21-173 "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of Clarification Regarding Institutional Eligibility for PAR-21-169 "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of NIMH Intent to Issue Funding Opportunity Announcements and Notice of Special Interest for COVID-19 and Mental Health Research
National Institute of Mental Health
- Request for Information: Soliciting Input on Research Priorities for Amyotrophic Lateral Sclerosis (ALS)
National Institute of Neurological Disorders and Stroke
Notice of Changes to Funding Opportunities
- Notice of Change to Key Dates for NIDA PAR-21-183, " Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)"
National Institute on Drug Abuse
- Notice of Change to Award Information for RFA-DK-21-027, "National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to Award Information for RFA-DK-21-035, "Coordinating Unit for the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U24 - Clinical Trial Not Allowed)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice to Extend the Application Due Date for RFA-FD-22-004 - "Renewal - Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition, JIFSAN (U01) Clinical Trial Not Allowed"
Food and Drug Administration
- Notice to Extend the Application and Letter of Intent Due Dates for RFA-FD-22-013 - "Development of Advanced Analytical Methods for Analyzing Diastereomer Compositions in Oligonucleotides (U01) Clinical Trial Not Allowed"
Food and Drug Administration
- Notice of Change to Award Budget for PHS 2021-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
Office of the Director, NIH
Notices of Intent to Publish
- Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase III)
Office of the Director, NIH
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer's Disease and Related Dementias
National Institute on Aging
- Notice of Special Interest (NOSI): In vivo Synaptic Function in Alzheimer's Disease and Related Dementias
National Institute on Aging
- Notice of Special Interest (NOSI): Selective Cell and Network Vulnerability in Aging and Alzheimers Disease
National Institute on Aging
- Notice of Special Interest (NOSI): Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease
National Institute on Aging
- Notice of Special Interest (NOSI): Deciphering the Glycosylation Code of Alzheimer's Disease
National Institute on Aging
- Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease.
National Institute on Aging
- Notice of Special Interest (NOSI): Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience
National Institute on Aging
- Notice of Special Interest (NOSI): Dementia Care Research: Programs and services for persons with dementia
National Institute on Aging
- Notice of Special Interest (NOSI): Behavioral and Social Science Priority Areas in Dementia Care Partner/Caregiver Research
National Institute on Aging
- Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimers Disease and Related Dementias
National Institute on Aging
- Notice of Special Interest (NOSI): Dementia Care Workforce for Those Living with Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD)
National Institute on Aging
- Notice of Special Interest (NOSI): Sex and Gender Differences in Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD)
National Institute on Aging
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Human Cell Biology of Alzheimer's Disease Genetic Variants
National Institute on Aging
- Notice of Special Interest (NOSI): Role of Age-Associated Metabolic Changes in Alzheimer's Disease
National Institute on Aging
- Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors
National Cancer Institute
- Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences
National Institute of General Medical Sciences
- Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients Use of Genomic Information
National Human Genome Research Institute
- Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Funding Opportunities
- Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed)
Only institutions with research non-human primate colonies currently supported by NIH are eligible to apply.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early Career and Mid-career Investigators (K18 Clinical Trials Not Allowed)
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
- High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
The BIG Program is limited to institutions that have not received S10 instrumentation funding of $250,001 or greater in any of the preceding 3 Federal fiscal years (FY). The UIowa is not eligible.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
National Institute on Aging
- Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required)
National Institute on Aging
- Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
- Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
- Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
- Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
- Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
- Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Cancer Institute
- U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional)
National Cancer Institute
John E. Fogarty International Center
- HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional)
- HEAL Initiative: HEAL Data2Action Research Adoption Support Center (U2C Clinical Trial Optional)
- HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
- Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required)
- Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
National Heart, Lung, and Blood Institute
- Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
- Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
- Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
- Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional)
National Institute of Mental Health
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
- Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed)
- Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed)
- Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
- Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
- HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.